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Cholesterol is a multifunctional lipid that plays important metabolic and structural roles
in the eukaryotic cell. Despite having diverse lifestyles, the obligate intracellular bacterial
pathogensChlamydia, Coxiella, Anaplasma, Ehrlichia, and Rickettsia all target cholesterol
during host cell colonization as a potential source of membrane, as well as a means to
manipulate host cell signaling and trafficking. To promote host cell entry, these pathogens
utilize cholesterol-rich microdomains known as lipid rafts, which serve as organizational
and functional platforms for host signaling pathways involved in phagocytosis. Once a
pathogen gains entrance to the intracellular space, it can manipulate host cholesterol
trafficking pathways to access nutrient-rich vesicles or acquire membrane components
for the bacteria or bacteria-containing vacuole. To acquire cholesterol, these pathogens
specifically target host cholesterol metabolism, uptake, efflux, and storage. In this
review, we examine the strategies obligate intracellular bacterial pathogens employ
to manipulate cholesterol during host cell colonization. Understanding how obligate
intracellular pathogens target and use host cholesterol provides critical insight into the
host-pathogen relationship.
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INTRODUCTION
To establish the intracellular niche, obligate intracellular pathogens must overcome numerous
obstacles. First, the pathogen must recognize and bind to their target host cell. Second,
they must penetrate the host cell plasma membrane, most often by tricking the host cell
into engulfing the pathogen through phagocytosis. Once inside the target cell, the pathogen
initially resides in a membrane-bound compartment called the phagosome that, under normal
conditions, progressively acidifies to a mature phagolysosome. While some bacteria can thrive
in this environment, others prevent fusion between the phagosome and lysosome, or escape the
phagosome and replicate in the host cytosol. For vacuolar pathogens, the pathogen-containing
vacuole must protect from the host innate immune the bacteria system, while at the same
time allowing access to nutrients required for bacterial growth. In order to establish these
highly specialized intracellular niche, pathogens manipulate host gene expression, metabolism, or
trafficking pathways.
In contrast to facultative intracellular or extracellular pathogens, obligate intracellular pathogens
rely on the host cell for a large percentage of their growth requirements. As a result, obligate
intracellular pathogens have sophisticated mechanism to manipulate the host cell to obtain
essential nutrients. One of the targeted host cell factors is cholesterol, a major lipid component
of eukaryotic membranes that strongly influences membrane structure and function. Structurally,
cholesterol affects membrane fluidity and permeability, with higher cholesterol levels increasing
membrane rigidity. Cholesterol concentrates in membrane microdomains known as lipid rafts,
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which are specialized signaling platforms involved in signal
transduction (Simons and Toomre, 2000). Further, intracellular
cholesterol is a critical player in Golgi trafficking (Stüven et al.,
2003), endocytic trafficking (van der Kant et al., 2013), and intra-
organelle membrane contact sites (Eden et al., 2016). Pathogenic
bacteria target cholesterol not only to gain entry to host cells
but also to hijack host cell signaling pathways favorable for
intracellular survival. This review discusses the role of cholesterol
in host-pathogen interactions, from the perspective of obligate
intracellular bacterial pathogens that reside in membrane-bound
compartments (Chlamydia, Coxiella, Anaplasma, and Ehrlichia)
or in the host cell cytoplasm (Rickettsia).
INTRACELLULAR LIFESTYLES
Chlamydia spp.
Chlamydia are obligate intracellular bacteria that cause trachoma
(C. trachomatis serovars Ab, B, Ba, C), urogenital tract infections
(C. trachomatis serovars D-K), lymphogranuloma venereum (C.
trachomatis serovar L1, L2, L3) and pneumonia (C. pneumoniae
and C. psittaci). Chlamydia have a biphasic life cycle, alternating
between the infectious elementary body (EB) and the replicative
reticulate body (RB). Following EB attachment to the host cell,
the Chlamydia Type III secretion system (T3SS) injects proteins
into the host cell cytosol, inducing actin rearrangement and
bacterial uptake (Clifton et al., 2004). Once internalized, the
bacteria block phagosomematuration and reside in a membrane-
bound compartment known as the inclusion. The inclusion
membrane contains both host and bacterial proteins and is
non-fusogenic with endosomes and lysosomes, but intercepts
nutrient-rich Golgi-derived vesicles and multivesicular bodies in
the recycling pathway (Hackstadt et al., 1995, 1996; Heinzen et al.,
1996; Beatty, 2006). Within the inclusion, EBs differentiate into
RBs, which replicate and eventually differentiate back to EBs
prior to host cell egress and reinfection. During this infectious
cycle, Chlamydia T3SS effector proteins are translocated across
the inclusion membrane and into the host cytosol, where they
manipulate host pathways to divert nutrients such as amino acids,
lipids, and iron to the inclusion (reviewed in Bastidas et al., 2013).
Coxiella burnetii
Coxiella burnetii is the causative agent of human Q fever,
an aerosol-borne zoonotic disease characterized by flu-
like symptoms during acute infection and endocarditis in
chronically infected patients. Following phagocytosis of the
environmentally stable C. burnetii small cell variant (SCV),
the C. burnetii-containing phagosome matures through the
endocytic pathway to a phagolysosome (Howe and Mallavia,
2000; Howe et al., 2003). The acidic pH of the phagolysosome
activates C. burnetii metabolism and differentiation to the
replicative form known as the large cell variant (LCV) (Hackstadt
andWilliams, 1981). At this point, fusion between the C. burnetii
parasitophorous vacuole (PV) and host endosomes, lysosomes,
and autophagosomes creates a large, phagolysosome-like
vacuole that promotes bacterial replication (reviewed in Voth
and Heinzen, 2007). C. burnetii actively manipulates host cell
functions such as apoptosis and vesicular trafficking by secreting
effector proteins into the cytoplasm through the Dot/Icm Type
IV secretion system (T4SS) (reviewed in Moffatt et al., 2015).
Anaplasma phagocytophilum and Ehrlichia
chaffeensis
Anaplasma phagocytophilum and Ehrlichia chaffeensis are tick-
borne obligate intracellular bacterial pathogens belonging to
the family Anaplasmataceae. A. phagocytophilum, the causative
agent of human granulocytic anaplasmosis, infects human
neutrophils and multiplies within vacuoles called inclusions or
morulae. The A. phagocytophilum inclusion does not contain
endosomal or lysosomal markers, although it interacts with the
nutrient-rich endocytic and autophagic pathways (Webster et al.,
1998; Mott et al., 1999; Niu et al., 2006). Like C. burnetii,
the A. phagocytophilum T4SS effector proteins modulate
host cell processes including autophagosome formation and
SUMOylation (Niu et al., 2010; Al-Khedery et al., 2012; Beyer
et al., 2015).
Ehrlichia chaffeensis exclusively infects human monocytes and
macrophages and causes human monocytic ehrlichiosis. Similar
to A. phagocytophilum inclusions, E. chaffeensis inclusions do
not contain late endosomal markers and only weakly stain for
lysosomal vacuolar ATPase (Barnewall et al., 1997). However,
in contrast to A. phagocytophilum, E. chaffeensis inclusions
are labeled with early endosomal markers, suggesting the E.
chaffeensis resides in a vacuolar niche similar to an early
endosome (Mott et al., 1999). In addition, the E. chaffeensis T4SS
effector protein Etf-1 induces autophagy and redirects nutrients
to the inclusion to support E. chaffeensis intracellular growth (Lin
et al., 2016).
Rickettsia spp.
Rickettsia spp. are small coccobacilli and the causative agents
of Rocky Mountain Spotted Fever (R. rickettsia), Mediterranean
spotted fever (R. conorii), louse-borne typhus (R. prowazekii),
and scrub typhus (Orientia tsutsugamushi). Most commonly
transmitted to humans by arthropods, Rickettsia spp. infect
and replicate in the endothelial cells of blood vessels and
major organs. Following uptake by the host cell, rickettsial
phospholipase degrades the phagosomalmembrane, releasing the
bacteria into the cytoplasm where they replicate freely (Walker
et al., 2001). Several species ofRickettsia spread from cell to cell by
reorganizing and mobilizing host cell actin (Heinzen et al., 1993),
while O. tsutsugamushi escapes the host cell through a process
similar to viral budding (Ogawa et al., 2014).
ROLE OF CHOLESTEROL IN BACTERIAL
ENTRY AND EXIT
Cholesterol-rich microdomains in the plasma membrane, known
as lipid rafts, play a key role during pathogen attachment and
entry into host cells. Lipid rafts are enriched in cholesterol, with
3- to 5-fold more cholesterol than the surrounding membrane
(Pike, 2003). Lipid rafts also have higher concentrations of
sphingolipids and signal transduction proteins such as integrins,
kinases, phosphatases, and G protein-coupled receptors (Brown
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and Rose, 1992; Sargiacomo et al., 1993; Chun et al., 1994;
Lisanti et al., 1994; Gorodinsky and Harris, 1995; Liu et al.,
1996; Mineo et al., 1996; Bickel et al., 1997). Caveolae, a
morphologically distinct subset of lipid rafts with a flask-shaped
structure, contain cholesterol-binding caveolin proteins involved
in clathrin-independent endocytosis (Chang et al., 1992; Stang
et al., 1997; Orlandi and Fishman, 1998; Schubert et al., 2001;
Lai, 2003). As lipid rafts are key components of cell signaling and
endocytosis, bacterial pathogens often target lipid rafts during
host cell entry. Hijacking raft-associated signaling proteins
promotes internalization of intracellular bacteria and subsequent
development of the intracellular niche.
Chlamydia spp.
The role of lipid rafts during Chlamydia host cell entry has
been controversial. Early studies found that C. trachomatis
serovar L2 and C. psittaci strain GPIC was associated with lipid
rafts during infection of HeLa cells, and cholesterol depletion
usingmethyl-beta-cyclodextrin (MβCD) inhibited bacterial entry
in a dose-dependent manner (Jutras et al., 2003). Disrupting
lipid rafts with the cholesterol-binding compounds filipin and
nystatin impaired entry of C. pneumoniae, C. psittaci, and
C. trachomatis serovars E, F, and K (but not A, B, and C)
into HeLa cells (Stuart et al., 2003) and serovar K into J774
macrophages (Norkin et al., 2001). Further, although caveolin
was not necessary for entry, these strains co-localized with the
major caveolae protein caveolin-1 (Norkin et al., 2001; Stuart
et al., 2003). Recent work suggests C. pneumoniae uptake by
HL cells, but not attachment, also involves lipid rafts (Korhonen
et al., 2012). Similarly, Gabel reported that MβCD cholesterol
extraction inhibited entry of C. trachomatis serovars D, E, K,
and L2 into HeLa cells (Gabel et al., 2004). However, disrupting
lipid raft function with filipin, nystatin, or antibodies against
cholera toxin B bound to lipid raft GM1 ganglioside had no
effect on infection (Gabel et al., 2004). This study also did not
find bacteria associated with lipid rafts or caveolin. Further,
GPI-anchored proteins, which are enriched in lipid rafts, were
not required for C. trachomatis entry into CHO cells (Jutras
et al., 2003). In support of these findings, C. trachomatis serovar
L2 entry into cholesterol-free DHCR24−/− mouse embryonic
fibroblasts was identical to cholesterol supplemented cells (Gilk
et al., 2013).
The discrepancies between these studies may be attributed to
differences in bacterial isolates, host cell type, or pleotropic effects
onmembrane function byMβCD (Zidovetzki and Levitan, 2007).
It is also possible that multiple, redundant entry pathways exist
using different host cell receptors. Recent studies have shown
that two C. pneumoniae proteins, adhesin CPn0473 and invasin
Pmp21, bind to host epidermal growth factor receptor (EGFR)
and trigger lipid raft-mediated uptake (Mölleken et al., 2013;
Fechtner et al., 2016). C. trachomatis also adhered to the lipid raft
protein EphrinA2 receptor (EphA2) (Chakraborty et al., 2012;
Subbarayal et al., 2015), and the C. trachomatis invasin protein
Ctad1 bound to β1 integrin in lipid rafts during internalization
(Stallmann and Hegemann, 2016). Targeting multiple host cell
lipid raft receptors may broaden host cell tropism and increase
the potential for successful host cell colonization.
C. burnetii
During host cell entry, C. burnetii utilizes αVβ3 integrin
(Capo et al., 1999), a transmembrane protein found in lipid
rafts (Triantafilou and Triantafilou, 2003). In cholesterol-free
DHCR24−/− fibroblasts, C. burnetii internalization decreased
almost 90% compared to DHCR24−/− fibroblasts supplemented
with exogenous cholesterol (Gilk et al., 2013). Blocking
αVβ3 with antibodies or the αVβ3 ligand vitronectin further
reduced internalization in DHCR24−/− fibroblasts, reinforcing
the significance of lipid rafts in C. burnetii internalization.
Targeting the αVβ3 pathway may be a strategy employed by
C. burnetii to evade the host immune response. αVβ3 normally
functions during macrophage phagocytosis of apoptotic cells
(Wu et al., 2005), a process that suppresses the immune response
by inhibiting macrophage production of interleukin (IL)-1β,
IL-8, tumor necrosis factor (TNF)- α, leukotriene C4, and
thromboxane B2 (Fadok et al., 1998). Thus, the αVβ3-dependent
pathway may enable C. burnetii to enter host cells without
eliciting an inflammatory response.
A. phagocytophilum and E. chaffeensis
A. phagocytophilum and E. chaffeensis have also been reported to
utilize lipid rafts or caveolae for host cell entry (Lin and Rikihisa,
2003b). Similar to Chlamydia spp., cholesterol depletion using
MβCD, or lipid raft disruption with nystatin or NBD-cholesterol,
blocked infection by both A. phagocytophilum and E. chaffeensis
(Lin and Rikihisa, 2003b). Removing host surface GPI-anchored
proteins with phosphoinositide phospholipase C (PI-PLC) also
inhibited entry of both bacterial species, suggesting lipid raft-
associated GPI-anchored proteins are necessary for infection.
Depletion of plasma membrane caveolae with cholera toxin B
reduced A. phagocytophilum and E. chaffeensis entry by 90%, and
both GM1 and caveolin-1 localized to early inclusions (Lin and
Rikihisa, 2003b). These data suggest that A. phagocytophilum and
E. chaffeensis utilize caveolae-mediated endocytosis for host cell
entry.
Rickettsia spp.
Lipid rafts are involved in both host cell entry and exit of different
Rickettsia spp.MβCD extraction of plasmamembrane cholesterol
blocked R. conorii uptake (Martinez et al., 2005). Further, the R.
conorii outer membrane protein OmpB bound the host protein
Ku70, a subunit of DNA-dependent protein kinase (DNA-PK)
which is found in the nucleus and plasma membrane lipid rafts
(Koike, 2002; Lucero et al., 2003; Martinez et al., 2005). Ku70
co-localized with R. conorii attached to Vero or HeLa cells,
and an antibody directed against the extracellular N-terminus of
Ku70 decreased R. conorii entry (Martinez et al., 2005). Thus,
R. conorii OmpB facilitates host cell entry by binding to the
lipid raft-associated host protein Ku70. In addition to OmpB,
R. conorii OmpA bound the lipid raft integrins α2 and β1 on
the cell surface (Upla et al., 2004; Hillman et al., 2013). While
the signaling cascade triggered by Ku70 is not known, it may
mimic integrin signaling and lead to actin-mediated phagocytosis
(Martinez et al., 2005).
O. tsutsugamushi was found in lipid rafts of infected cells,
suggesting the bacteria associate with lipid rafts (Kim et al.,
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2013). However, the inability of MβCD or filipin to impair O.
tsutsugamushi host cell entry indicates that cholesterol or lipid
rafts are not involved (Kim et al., 2013). While caveolin did not
associate directly with the bacteria, the O. tsutsugamushi protein
HtrA co-localized with caveolin during host cell exit, a process
where the bacteria causes the plasma membrane to bulge out
similar to viral budding (Kim et al., 2013). Thus, it appears that
plasmamembrane cholesterol is not involved inO. tsutsugamushi
entry but plays a key role during bacterial egress from host cells.
Targeting lipid rafts is clearly an important strategy by obligate
intracellular pathogens, with Chlamydia spp., C. burnetii, A.
phagocytophilum, E. chaffeensis, and R. conorii all utilizing lipid
rafts during host cell entry. Lipid rafts serve as signaling platforms
to trigger host cell actin rearrangement and phagocytosis, thus
allowing the bacteria to subvert host cell machinery to gain entry.
Further, caveolin-mediated entry may facilitate development of
the intracellular niche for vacuolar pathogens. For example,
Chlamydia inclusion membrane caveolin may facilitate direct
interception of Golgi-derived exocytic vesicles that are rich in
sphingolipids and other nutrients essential for Chlamydia growth
(Hackstadt et al., 1996; Van Ooij et al., 2000). While the presence
of caveolin on the C. burnetii PV has not been explored, caveolin
most likely plays an important role during host cell colonization
by Chlamydia spp., A. phagocytophilum, and E. chaffeensis.
CHOLESTEROL-RICH MICRODOMAINS
ON PATHOGEN-CONTAINING VACUOLES
While the functions are less understood, cholesterol-rich
microdomains are also found on the membrane of bacteria-
containing vacuoles.
Chlamydia spp.
Filipin labeling of C. trachomatis-infected HeLa cells revealed
cholesterol-rich microdomains on the inclusion membrane
(Carabeo et al., 2003; Mital et al., 2010). These microdomains
co-localized with four chlamydial inclusion membrane proteins
(IncB, Inc101, Inc222, and Inc850) and active host Src-family
kinases (SFKs) (Mital et al., 2010). SFKs were not required for
Inc microdomain formation, leaving the relationship between
SFKs and Inc proteins unclear (Mital and Hackstadt, 2011).
It is not known whether the Incs are recruited to these
inclusion microdomains, or if the Inc proteins themselves
trigger microdomain formation. Inc222 and Inc850 stably
interact with one another and may form a complex within
the inclusion microdomains. While the functions of IncB,
Inc101, and Inc222 are unknown, Inc850 may play a critical
role during inclusion development by mediating microtubule-
dependent trafficking of the nascent chlamydial inclusion to the
perinuclear microtubule organizing center (MTOC) (Campbell
et al., 1989a,b; Grieshaber et al., 2003). Inc850 was found to
bind dynein light chain, DYNLT1, thus facilitating interactions
between the inclusion and the host microtubule network
that are required for trafficking to the MTOC (Mital et al.,
2010, 2015). Inclusion trafficking to the MTOC is thought to
promote homotypic fusion between inclusions, which serves
as a potential mechanism to share nutrients or exchange
genetic material (Richards et al., 2013). Chlamydia clinical
strains that cannot undergo homotypic fusion cause less severe
disease with fewer recoverable bacteria, suggesting this is an
important virulence factor (Geisler et al., 2001). With the
recent development of genetic tools in Chlamydia, the role
of Inc850 in inclusion trafficking and virulence can now be
tested.
In addition to the Incs, the host SFKs Fyn and Src
localized to cholesterol-rich microdomains of C. trachomatis
and C. pneumoniae inclusions but not the rodent species
C. caviae and C. muridarum (Mital et al., 2010; Mital and
Hackstadt, 2011). The SFKs are non-receptor membrane-
associated tyrosine kinases that regulate microtubule-dependent
trafficking by phosphorylating tubulin and binding to dynein-
associated proteins (Macurek et al., 2008; Colello et al., 2010;
Levi and Shalgi, 2010). SFK activity was necessary for dynein-
dependent trafficking of the nascent C. trachomatis inclusion to
the MTOC (Mital et al., 2010). In addition, Fyn was involved
in sphingomyelin acquisition by Chlamydia,most likely through
microtubule-dependent trafficking (Mital and Hackstadt, 2011).
Chlamydia species that do not recruit SFKs to their inclusion
membranes do not traffic to the MTOC but have increased
inclusion development and bacterial growth in SFK-deficient
cells, suggesting SFKs restrict growth of some Chlamydia species
(Mital et al., 2010; Mital and Hackstadt, 2011).
C. burnetii
TheC. burnetii PVmembrane is sterol-rich and contains the lipid
raft proteins flotillin-1 and flotillin-2 (Howe and Heinzen, 2006).
It is not known, however, if there are organized microdomains
on the PV membrane, or if these proteins play a role during
C. burnetii infection. Like C. trachomatis, multiple C. burnetii
PVs in a host cell will fuse, though there is no evidence for
microtubule-dependent trafficking of the PV and the role of
homotypic fusion in pathogenesis is not known.
Cholesterol-rich microdomains have been found on the
pathogen-containing vacuoles of both C. trachomatis and
C. burnetii, though the function has only been explored in
C. trachomatis. Cholesterol or other sterols are also enriched
in the A. phagocytophilum inclusion (Xiong et al., 2009). In
addition to mediating microtubule-dependent trafficking as in
the case of C. trachomatis inclusion, cholesterol may play
a structural role in the membranes of pathogen-containing
vacuoles. For example, high cholesterol membranes are more
rigid and may create a stronger physical barrier between the
pathogen and host cell defenses. Further, cholesterol regulates
proteins involved in endosomal trafficking and fusion, and could




Endogenous cholesterol is synthesized in the endoplasmic
reticulum (ER) and trafficked to the plasma membrane before
distribution throughout the cell. The major source of exogenous
cholesterol is through receptor-mediated uptake of cholesterol
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bound to low density lipoprotein (LDL). LDL particles are
internalized by clathrin-mediated endocytosis and transported
through the endocytic pathway to lysosomes, where cholesterol
esters are hydrolyzed to free cholesterol for cellular use.
Regardless of the source, cholesterol is transported throughout
the cell by both vesicular and non-vesicular (e.g., cholesterol
transport proteins and membrane contact sites) trafficking
pathways.
Chlamydia spp.
While the bacteria lack the machinery to synthesize cholesterol,
it is found in the C. trachomatis membrane in addition to
inclusion microdomains (Wylie et al., 1997; Hatch andMcClarty,
1998; Stephens et al., 1998; Carabeo et al., 2003). Chlamydia
appears to actively acquire host cholesterol, as inhibiting bacterial
protein synthesis with chloramphenicol drastically decreased
inclusion cholesterol levels (Carabeo et al., 2003). This suggests
that bacterial proteins, possibly secreted into the host cytoplasm,
directly manipulate host cholesterol trafficking pathways. Both
de novo synthesized and exogenous LDL-derived cholesterol
trafficked to C. trachomatis inclusion through a microtubule-
dependent process and involved transit through the Golgi
apparatus before delivery to the inclusion membrane (Carabeo
et al., 2003). However, Golgi-dependent cholesterol trafficking
was not essential for Chlamydia replication, and cholesterol-
rich multivesicular bodies (MVBs) also deliver cholesterol to
the inclusion (Carabeo et al., 2003; Beatty, 2006, 2008). The
MVB pathway may be essential, as disruption of the MVB
trafficking decreased cholesterol in the C. trachomatis inclusion,
delayed inclusion maturation, and reduced bacterial growth
(Beatty, 2006, 2008). Interestingly, C. trachomatis inclusion
formation and bacterial growth was unaffected in cholesterol-
free DHCR24−/− mouse embryonic fibroblasts, suggesting
cholesterol precursors may be sufficient for C. trachomatis
infection (Gilk et al., 2013).
In addition to Golgi-dependent and MVB trafficking, a third
mechanism of cholesterol transport to the inclusion utilizes the
high-density lipoprotein (HDL) biogenesis machinery involved
in cholesterol efflux. HDL is formed when cholesterol and
phospholipids are transported to extracellular ApoA-1 by the
lipid binding proteins ATP-binding cassette transporters A1 and
G1 (ABCA1, ABCG1), and CLA1. Intriguingly, while ABCA1,
CLA1, and ApoA-1 localized to the inclusion membrane, both
CLA1 and ApoA-1 were also found in discrete foci within the
inclusion lumen (Cox et al., 2012). siRNA knockdown of ABCA1
or pharmaceutical inhibitors of ABCA1 and CLA1 transporter
activity significantly reduced C. trachomatis growth (Cox et al.,
2012). While the mechanism is not clear, it is possible that
C. trachomatis diverts these proteins to the inclusion as a
mechanism to obtain cholesterol.
C. burnetii
The C. burnetii PV is sterol-rich, although filipin labeling does
not indicate that cholesterol or other sterols are present in
the C. burnetii envelope (Howe and Heinzen, 2006). Despite
encoding two unique eukaryote-like sterol reductase homologs
(Seshadri et al., 2003; Beare et al., 2009; Gilk et al., 2013),
C. burnetii does not appear to synthesize cholesterol and instead
obtains cholesterol from the host cell. Cholesterol-rich MVBs
fuse with the PV (Gilk et al., 2013) and both endogenous and
LDL-derived cholesterol traffic to the PV through unknown
pathways (Mulye et al., 2017). C. burnetii also interacts with host
cholesterol trafficking by recruiting the host cholesterol-binding
protein ORP1L (oxysterol binding protein related protein 1 long)
to the PV in a T4SS-dependent manner (Justis et al., 2017).
ORP1L is an endosome/lysosome-localized Rab7 effector protein
that serves two conformation-dependent functions in host cells
(Rocha et al., 2009). When bound to cholesterol, ORP1L takes
on a compact conformation, allowing Rab7-RILP to interact with
dynein motors and direct minus-end transport of endosomes
along microtubules. Alternately, when not bound to cholesterol,
ORP1L is in an extended conformation and binds to the VAP
proteins on the ER, participating in endosome/lysosome-ER
membrane contact sites (Rocha et al., 2009; van der Kant et al.,
2013). Interestingly, while the C. burnetii PV membrane is
sterol-rich, fluorescent co-localization and electron microscopy
suggest that ORP1L participates in PV-ER contact sites and
is likely not binding cholesterol on the PV membrane (Justis
et al., 2017). ORP1L was required for optimal C. burnetii PV
expansion possibly through ORP1L-dependent trafficking to the
PV (Justis et al., 2017). ORP1L may also be involved in transfer
of cholesterol from the PV to the ER, similar to the proposed
role of ORP1L during adenovirus infection (Cianciola et al.,
2013).
Inhibiting host cell cholesterol metabolism disrupted PV
morphology and bacterial replication, demonstrating that
cholesterol and other sterols play an important role in
C. burnetii infection (Howe and Heinzen, 2006). Although
cholesterol itself was not essential for C. burnetii infection
of cholesterol-free DHCR24−/− fibroblasts (Gilk et al., 2013),
increasing PV cholesterol through cholesterol supplementation
or pharmacological inhibitors was bactericidal (Mulye et al.,
2017). Intriguingly, C. burnetii death was due to increased PV
acidification when PV cholesterol levels were elevated (Mulye
et al., 2017). The proton pump vATPase plays a key role in
lysosomal acidification and has been localized to the C. burnetii
PV (Heinzen et al., 1996). vATPase activity is affected by
lysosomal membrane cholesterol (Cox et al., 2007), leading to
the possibility that cholesterol levels regulate PV pH through
vATPase.
A. phagocytophilum
Cholesterol is an important component of the A.
phagocytophilum and E. chaffeensis cell envelopes, providing
physical integrity in the absence of typical bacterial lipid A and
peptidoglycan (Lin and Rikihisa, 2003b). Cholesterol is also
enriched on the A. phagocytophilum inclusion membrane and
lumen (Xiong et al., 2009). Like Chlamydia and C. burnetii, A.
phagocytophilum lacks genes for cholesterol biosynthesis and
recruits host cholesterol by targeting cholesterol trafficking (Lin
and Rikihisa, 2003a). A. phagocytophilum-infected cells have
increased LDL uptake, resulting in 2-fold more cholesterol than
uninfected cells (Xiong et al., 2009). LDL-derived cholesterol was
trafficked to the A. phagocytophilum inclusion by the host cell
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protein NPC1 (Niemann-Pick disease, type C1), a cholesterol-
binding membrane protein required for cholesterol transfer
from endosomes and lysosomes to the ER (Karten et al., 2009).
Within 24 h of infection, A. phagocytophilum recruited NPC1 to
the inclusion membrane via NPC1-positive, LAMP1/2-negative
vesicles (Xiong and Rikihisa, 2012). Bacterial protein synthesis
was required for NPC1 recruitment, and bacterial growth
was significantly impaired in NPC1-deficient cells (Xiong and
Rikihisa, 2012). Furthermore, vesicle-associated membrane
protein 4 (VAMP4) and syntaxin 16, which participate in
LDL-cholesterol transport from NPC1 vesicles to the Golgi
network, were also recruited to the A. phagocytophilum inclusion
(Xiong and Rikihisa, 2012). Thus, A. phagocytophilum hijacks
NPC1-mediated LDL trafficking as a method to divert cholesterol
to the bacterial inclusion for incorporation into the bacterial
envelope and inclusion membrane.
Given that cholesterol plays important roles in both the
bacteria and vacuole membranes, it is no surprise that obligate
intracellular pathogens have devised multiple ways to recruit
host cell cholesterol. Cholesterol binding proteins, which serve to
move cholesterol between membranes, localize to the vacuoles of
both C. trachomatis and C. burnetii. Cholesterol-rich MVBs also
fuse with the C. trachomatis and C. burnetii vacuoles, and LDL
trafficking of internalized extracellular cholesterol is important
for C. trachomatis, C. burnetii, and A. phagocytophilum. In the
case of A. phagocytophilum, the bacteria target a specific subset of
LDL-positive vesicles, while the underlying mechanism of LDL
trafficking to the C. trachomatis inclusion is not known. Finally,
the promiscuous fusogenicity of the C. burnetii PV may account
for LDL delivery to this vacuole. Most likely, other undiscovered
pathways also deliver cholesterol to the bacteria, all serving to
provide this important resource to the intracellular niche.
BACTERIAL MODIFICATION OF
CHOLESTEROL
While not possessing the full biosynthetic machinery to generate
cholesterol de novo, both C. trachomatis and C. burnetii
express cholesterol-modifying enzymes which may modify host
cell cholesterol or cholesterol precursors.
C. trachomatis
The C. trachomatis gene CT149 is a putative carboxylic esterase
containing a cholesterol recognition consensus sequence and two
GXSXG cholesterol esterase motifs (Peters et al., 2012). Further,
recombinant CT149 exhibited cholesterol esterase activity in
vitro, and CT149 ectopic expression in HeLa cells decreased
cholesterol ester levels, with a corresponding increase in free
cholesterol (Peters et al., 2012). Antibodies generated against
CT149 localized this protein to the bacteria and not the host
cytoplasm, suggesting CT149 functions inside the inclusion
(Peters et al., 2012). Interestingly, lipid droplets (LDs), which
store cholesterol esters, were observed inside the chlamydial
inclusion (Cocchiaro et al., 2008), presenting the possibility that
CT149 liberates cholesterol from LDs for use by the bacteria.
C. burnetii
C. burnetii expresses two eukaryotic-like sterol reductase
enzymes, CBU1158 and CBU1206 (Seshadri et al., 2003; Beare
et al., 2009). CBU1206 has homology to 124 sterol reductases,
which function in the final step of mammalian cholesterol or
yeast ergosterol synthesis (Beare et al., 2009). Heterologous
expression of CBU1206 in Saccharomyces cerevisae functionally
complements deletion of the yeast 124 sterol reductase erg4,
indicating CBU1206 can modify sterols (Gilk et al., 2010).
However, if CBU1206 modifies cholesterol in C. burnetii or host
cells is unknown. Further, CBU1206 contains nine predicted
transmembrane domains and is most likely in the C. burnetii
cell envelope, which raises interesting questions about when
and where CBU1206 might modify host sterols (Gilk et al.,
2010). The enzymatic capability for the putative C. burnetii 17
sterol reductase CBU1158 remains unexplored. Determining the
importance of the C. burnetii putative sterol reductases during
infection, along with their substrate specificity and location of
action, will be critical to understanding the role of cholesterol and
other sterols during C. burnetii infection.
MANIPULATING CHOLESTEROL
HOMEOSTASIS
Eukaryotic cells tightly regulate cholesterol levels by balancing
metabolism (biosynthesis and breakdown), uptake, efflux, and
storage. De novo biosynthesis occurs in the ER, with the
conversion of HMG-CoA tomevalonate byHMG-CoA reductase
(HMGR) being the rate-limiting step. Cellular cholesterol levels
can also be increased through uptake of cholesterol bound to
LDL via the LDL receptor (LDLR). Both biosynthesis and uptake
are regulated at the expression level by sterol regulatory element-
binding protein (SREBP) or liver X receptor (LXR) transcription
factors, which increase transcription of HMGR and LDLR under
low cholesterol conditions. When cellular cholesterol levels are
high, cholesterol can be transported out of the cell (i.e., effluxed),
broken down into bile acids or steroids, or esterified and stored
in LDs. Chlamydia spp., C. burnetii, and A. phagocytophilum all
target host cholesterol homeostasis, particularly at the level of
gene transcription.
Cholesterol Metabolism and Uptake
Chlamydia spp.
C. pneumoniae has been linked to atherosclerosis, a disease
that results from dyslipidemia, or increased levels of circulating
lipids. In mice, peripheral blood monocytes can spread C.
pneumoniae from the lung to the liver, a key site of lipid
metabolism (Moazed et al., 1998; Marangoni et al., 2006). A
recent in vivo study found that C. pneumoniae-infected mice had
decreased hepatic bile acid levels and increased serum cholesterol
levels, as compared to uninfected or C. trachomatis-infected
mice (Marangoni et al., 2015). These changes have been linked
to Cyp7a1 (cholesterol 7α-hydroxylase), a host enzyme that
catalyzes cholesterol breakdown into bile acids. Along with two
transcription factors involved in regulating Cyp7a1 expression,
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lxr-α and srebp1c, cyp7a1was downregulated in C. pneumoniae-
infected liver cells (Marangoni et al., 2015). A separate study
reported a dose-dependent decrease in cyp7a1 promoter activity
in C. pneumoniae-infected human hepatocytes (Michelini et al.,
2012). Together, these data suggest that through Cyp7a1, C.
pneumoniae downregulates cholesterol catabolism in liver cells.
C. pneumoniae also altered uptake of serum cholesterol in the
mouse liver, by downregulating ldlr expression and upregulating
expression of idol (inducible degrader of the LDLR) (Marangoni
et al., 2015). By decreasing cholesterol catabolism in the liver,
while also decreasing cholesterol uptake,C. pneumoniae infection
may lead to increased circulating cholesterol and promote
atherosclerosis.
In contrast to liver cells, C. pneumoniae increased LDL
uptake in infected human monocyte-derived macrophages
(Kalayoglu and Byrne, 1998). This led to formation of foam
cells, which are lipid-laden cells important in atherosclerosis
progression. LDL uptake also increased approximately 2.5-fold in
C. pneumoniae-infected humanmonocytes and human umbilical
vein epithelial (HUVEC) cells (Yoshida et al., 2006; Evani and
Ramasubramanian, 2016). In HUVEC cells, this was partially due
to increased expression of cholesterol uptake receptors, including
scavenger receptor A, LOX-1, and CD36, which all internalize
oxidized low density lipoprotein (oxLDL) (Yoshida et al., 2006;
Campbell et al., 2013; Sun et al., 2014). Interestingly, glycan from
C. pneumoniae, but not C. trachomatis, bound and activated
LOX-1 (Campbell et al., 2013). Recombinant C. pneumoniae
Hsp60 also increased LOX-1 expression in endothelial cells of
hypercholesterolemic rabbits, further suggesting that the bacteria
actively interact with the LOX-1 pathway to increase LDL uptake
(Lin et al., 2011).
Less is known about C. trachomatis manipulation of
cholesterol metabolism. In human trophoblasts, C. trachomatis
downregulated hmgr, leading to lower levels of cholesterol and
the cholesterol-derived steroids estrogen and progesterone;
this is hypothesized to impair trophoblast implantation
and placentation during pregnancy (Azenabor et al., 2007).
Although not the primary target organ, C. trachomatis has
been found in mouse liver lesions and can cause perihepatitis
in humans (Barteneva et al., 1996). Gene expression profiles
in C. trachomatis-infected mouse livers reported upregulation
of lxrα, lxrβ, and cyp7a1, suggesting cholesterol catabolism is
elevated (Marangoni et al., 2015). C. trachomatis downregulated
ldlr in human HepG2 hepatocellular cells, suggesting the
bacteria decreases cholesterol uptake (Bashmakov et al.,
2010). Cholesterol biosynthesis appears to be critical for
C. trachomatis infection, as the HMGR inhibitor mevastatin
reduced C. trachomatis growth (Bashmakov et al., 2010). The
requirement for de novo host synthesized cholesterol would
suggest sterol intermediates or cholesterol metabolites are
important for C. trachomatis infection of liver cells.
C. burnetii
C. burnetii-infected Vero cells had a 73% increase in cellular
cholesterol at 6 days post-infection, as compared to mock
infected cells (Howe and Heinzen, 2006). Pharmaceutical
inhibitors of either HMGR or LDL uptake blocked PV formation
and bacterial growth, and both hmgr and ldlr were upregulated
during C. burnetii infection of Vero cells (Howe and Heinzen,
2006). Intriguingly, this upregulation was not observed until
4 days post-infection, when the C. burnetii PV is large and
the bacteria are in logarithmic growth. However, at 6 days
post-infection the expression levels returned to the same level
as mock-infected cells (Howe and Heinzen, 2006) indicating
a temporal regulation of cholesterol biosynthesis and uptake.
Supporting this hypothesis, C. burnetii PV size and growth were
found most sensitive to cholesterol levels only during the first
2 days of infection (Mulye et al., 2017). As elevated cholesterol
in the PV is bacteriolytic, it is possible that C. burnetii reduces
PV cholesterol during early stages of infection and increases
PV cholesterol later during PV maintenance. Given the role
cholesterol plays in PV fusion with endosomes, as well as PV pH,
C. burnetiimost likely tightly regulates PVmembrane cholesterol
during the infectious cycle.
A. phagocytophilum
Infection of human premyelocytic leukemia cell line (HL-60)
withA. phagocytophilum resulted in a 2-fold increase in total host
cell cholesterol level (Xiong et al., 2009). Inhibitor studies and
gene expression analyses revealed that A. phagocytophilum does
not require de novo cholesterol synthesis but acquires cholesterol
by upregulating LDLR at both the mRNA and the protein level
(Xiong et al., 2009). Interestingly, A. phagocytophilum does not
target SREBP, the primary transcription factor regulating ldlr
expression. Instead, the 3′ end of the ldlr mRNA transcript
is stabilized through an unknown mechanism (Xiong et al.,
2009). However, the extracellular signal-regulated kinase (ERK)
pathway appears to be involved, as ERK was upregulated during
A. phagocytophilum infection, and inhibiting the upstream
kinase MEK lowered ldlr expression levels and reduced bacterial
infection (Xiong et al., 2009). How the bacterium targets this
process still remains unknown, though it is clear that LDL uptake
is essential for A. phagocytophilum pathogenesis.
Cholesterol Efflux
Excess cholesterol can be exported out of the cell by the ATP-
binding cassette transporters ABCA1 and ABCG1. ABCG1 is
found primarily in endosomes, while ABCA1 cycles between
endosomes and the plasma membrane (Neufeld et al., 2001;
Tarling and Edwards, 2011). While both ABCA1 and ABCG1
transfer cholesterol to a number of extracellular particles,
ABCA1 promotes HDL assembly at the plasma membrane
through binding ApoA-1, a main component of HDL (Phillips,
2013). By targeting host cholesterol efflux pathways, intracellular
pathogens can further fine-tune host cholesterol to benefit
bacterial growth.
Chlamydia spp.
C. pneumoniae infection decreased cholesterol efflux by
downregulating expression of ABCA1 in multiple cell types
including A549 lung epithelial cell lines (Korhonen et al.,
2013), LDL-treated HUVEC cells (Sun et al., 2014), and THP-1
macrophage-derived foam cells (Zhao et al., 2014). ABCG1 was
also downregulated in C. pneumoniae-infected HUVECs (Sun
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et al., 2014). Experimental measurement of cholesterol efflux
to ApoA-1 showed a 50% decrease in C. pneumoniae-infected
THP-1 macrophage-like foam cells compared to uninfected or
heat-killed bacteria-infected cells (Zhao et al., 2014). Further, C.
pneumoniae appeared to downregulate host cholesterol efflux by
increasing microRNA miR-33 levels, which is produced from the
SREBP intron and downregulates ABCA1 (Zhao et al., 2014).
Upregulation of miR-33 was triggered by the innate immune
pattern recognition receptor TLR2 (toll like receptor 2) which
activates NF-kB-mediated upregulation of miR-33 upon bacterial
recognition (Zhao et al., 2014). While viable organisms were
required for this process, it is unknown if the bacteria are directly
activating TLR2 or if this is strictly a host immune response.
However, these data collectively indicate that C. pneumoniae
targets efflux as a mechanism to further increase the levels of
intracellular cholesterol.
C. burnetii
C. burnetii differentially regulated apoE and apoC gene
expression in THP-1 macrophages (Ren et al., 2003; Mahapatra
et al., 2010). In addition, a genome-wide RNA interference screen
in HeLa cells revealed that siRNA depletion of apolipoproteins
involved in lipid transport, including ApoA2, ApoC4, ApoL1,
ApoL2, and ApoL5, affected the total number of C. burnetii PVs
(McDonough et al., 2013). This suggests that cholesterol efflux
may play an important role during C. burnetii infection, although
the precise mechanisms and purpose are unknown.
Cholesterol Storage
Eukaryotic cells store excess cholesterol in lipid droplets (LD),
specialized organelles comprised of a phospholipid monolayer
surrounding a neutral lipid core of esterified cholesterol and
triacylglycerols. Prior to packaging in ER-derived LDs, excess
cholesterol is esterified by acyl CoA transferase (ACAT). LDs
are coated by a special class of proteins called perilipins, which
help prevent LD breakdown (Listenberger et al., 2007). LDs
serve as an important source of lipids for membrane synthesis
or energy metabolism, as well as immune modulators. Finally,
LD accumulation leads to foam cell formation, a hallmark of
atherosclerosis.
Chlamydia spp.
Atherosclerosis and foam cell formation play a significant role in
C. pneumoniae pathogenesis. C. pneumoniae infection increased
ACAT1 expression, and therefore esterified cholesterol, in THP-
1 cells (Liu et al., 2010). Along with the decreased cholesterol
efflux discussed earlier, this resulted in cholesterol accumulation
within the host cell and promoted foam cell formation. The
transcription factors LXR and the peroxisome proliferator-
activated receptors PPARα and PPARγ, which regulate the
expression of acat1 and other cholesterol homeostasis genes such
as abca1 and abcg1, have been implicated in C. pneumoniae-
induced foam cell formation (Chen et al., 2008; Naiki et al.,
2008; Mei et al., 2009; Liu et al., 2010). For example, C.
pneumoniae downregulated PPARα and PPARγ by targeting
the c-Jun N-terminal kinase (JNK) branch of the MAP kinase
pathway, leading to increased expression of acat1, abca1 and
abcg1 and promoting foam cell formation (Mei et al., 2009;
Liu et al., 2010). Treatment with PPARα and PPARγ agonists
reversed this effect. Thus, C. pneumoniae induces foam cell
formation by manipulating a signal transduction pathway that
regulates both LD formation (ACAT1) as well as cholesterol efflux
(ABCA1/G1).
During C. trachomatis infection, LDs were found inside
the inclusion and the number of cytoplasmic LDs increased
(Cocchiaro et al., 2008; Saka et al., 2015). LDs co-localized
with the C. trachomatis inclusion protein IncA at the inclusion
membrane and the lumen, suggesting that IncA participates in
LD translocation into the inclusion (Cocchiaro et al., 2008).
In addition, three C. trachomatis LD-associated proteins were
identified: Lda1, Lda2, and Lda3 (Kumar et al., 2006). While
the role of Lda1 and Lda2 have yet to be elucidated, Lda3 was
localized to the inclusion, cytoplasmic LDs, and LDs within the
inclusion (Cocchiaro et al., 2008). Lda3 overexpression decreased
PLIN2 association with LDs, suggesting Lda3 replaces PLIN2
on LDs to promote LD translocation into the inclusion. While
the role of LD translocation into the inclusion lumen is not
clear, LDs could serve as a source of energy or membrane
for intracellular C. trachomatis (Cocchiaro et al., 2008). As
discussed earlier, the putative C. trachomatis cholesterol esterase
(CT149) may hydrolyze cholesterol esters, freeing cholesterol
for bacterial use (Peters et al., 2012). Further supporting the
importance of LDs during C. trachomatis infection, inhibiting
LD formation with either pharmaceutical inhibitors or gene
knockouts significantly blocked C. trachomatis growth in
epithelial cells and fibroblasts (Kumar et al., 2006; Peters and
Byrne, 2015; Saka et al., 2015; Recuero-Checa et al., 2016).
A recent proteomic analysis discovered that the LD proteome
was altered during infection with C. trachomatis, with an
enrichment of host lipid metabolism and biosynthesis proteins
(Saka et al., 2015). Three additional bacterial inclusion proteins,
Cap1, CTL0882, and IncG, were also found in the LDs. Together,
these studies indicate thatC. trachomatis actively manipulates LD
formation, composition, and trafficking, potentially as a source of
energy or lipids.
C. burnetii
C. burnetii-containing foam cells have been found in heart valves
of an infected patient (Brouqui et al., 1994), and LDs were
observed in vitro in the C. burnetii PV lumen of infected human
alveolar macrophages (Graham et al., 2013). LD formation
may increase during infection, as the expression levels of
the LD coat protein PLIN2 and fatty acid binding protein
FABP4, which transfers fatty acids to the ER for packaging
in LDs, were upregulated in infected THP-1 cells (Ren et al.,
2003; Mahapatra et al., 2010). Furthermore, siRNA depletion
of patatin-like phospholipase domain-containing protein 2
(PNPLA2), the phospholipase involved in LD breakdown,
led to an increased number of C. burnetii PVs in HeLa
cells (McDonough et al., 2013). A similar observation was
made following depletion of the long chain fatty acyl-CoA
ligase ACSL6, which is important in neutral lipid synthesis
(McDonough et al., 2013; Teodoro et al., 2016). In addition,
treatment of monkey kidney epithelial cells (Vero cells) with an
LD-localized broad spectrum antiviral molecule ST699 inhibited
C. burnetii intracellular growth (Sandoz et al., 2014). These data
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point to a role for LD homeostasis during infection, though
it has not been determined if LDs are indeed targeted by
C. burnetii or if C. burnetii growth is altered when LD formation
is blocked.
A. phagocytophilum
A gene expression profiling study inA. phagocytophilum-infected
HL-60 cells revealed increased expression of the major LD
protein PLIN1 (de la Fuente et al., 2005; Manzano-Roman et al.,
2008). Further studies revealed PLIN1 expression increased with
bacterial replication, and siRNA knockdown of PLIN1 led to
a 50% decrease in A. phagocytophilum replication (Manzano-
Roman et al., 2008). As PLIN proteins are critical for LD
formation, LDs most likely play an important role during A.
phagocytophilim infection (Tansey et al., 2004; Brasaemle, 2007).
Rickettsia spp.
O. tsutsugamushi induced LD formation in mouse L-929
fibroblast cells (Ogawa et al., 2014). Although the difference in
cholesterol ester levels was not determined, lipid composition
analysis revealed O. tsutugamushi-induced LDs were enriched
in triacylglycerols and could serve as an energy source for the
bacteria. While these studies suggest that O. tsutsugamushi
induce LD accumulation, their contribution to bacterial
intracellular growth is yet to be determined.
CONCLUSION
For obligate intracellular bacteria, entry into the host cell
and subsequent formation and maintenance of a vacuolar or
cytoplasmic niche is essential for pathogen growth and survival.
Due to cholesterol’s multiple cellular functions, intracellular
pathogens target cholesterol to obtain nutrients, membrane,
or manipulate cellular signaling. This bacteria-host cholesterol
interaction occurs at various stages of infection including host
cell binding and internalization, niche formation, intracellular
replication, and dissemination. The pathogens discussed in this
review have appreciably different lifestyles with unique ways to
manipulate host cell cholesterol (Figure 1).
Chlamydia spp. initially interact with cholesterol-rich
lipid rafts during host cell entry, followed by targeting
multiple host cholesterol trafficking pathways in order to
establish the intracellular niche. Cholesterol is required in
both the Chlamydia envelope and the inclusion membrane.
While it has not been definitively demonstrated, cholesterol
most likely plays a structural role in the bacterial envelope.
FIGURE 1 | Overview of host cholesterol-pathogen interactions. For Rickettsia, Coxiella, Anaplasma, and Ehrlichia, attachment to the host cell plasma
membrane and subsequent host cell entry involves cholesterol-rich lipid rafts (red bars). The role of lipid rafts for Chlamydia is unclear, and may be species- or host
cell-specific, while Orientia utilizes lipid rafts for exit. Cholesterol (shown as red circles) is found in the pathogen-containing vacuoles, as well as the bacterial
membrane of Chlamydia, Anaplasma, and Ehrlichia. Golgi-derived vesicles, multivesicular bodies (MVB), and lipid droplets traffic to the Chlamydia inclusion and serve
as source of cholesterol. The source of cholesterol in the Coxiella vacuole is not clear, but may involve MVBs, while Anaplasma and Ehrlichia intercept LDL-derived
cholesterol. Chlamydia, Coxiella, and Anaplasma target host gene expression to manipulate cholesterol homeostasis (Dotted arrow pointing to the nucleus).
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TABLE 1 | Summary of manipulation of host cholesterol by obligate intracellular bacterial pathogens.
Bacteria Utilize lipid raft/caveolae






Bacterial manipulation of host cholesterol
homeostasis
Uptake Efflux Storage
Chlamydia spp. Controversial Yes Yes Yes Yes Yes
Coxiella burnetii Yes (entry) Yes Yes Yes Yes Yes
Anaplasma
phagocytophilum
Yes (entry) Unknown Yes Yes Unknown Yes
Ehrlichia chaffeensis Yes (entry) Unknown Yes Unknown Unknown Unknown
Rickettsia conorii Yes (entry) N/A N/A Unknown Unknown Unknown
Orientia
tsutsugamushi
Yes (exit) N/A N/A Unknown Unknown Yes
Inclusion membrane cholesterol serves at least two purposes.
First, inclusion cholesterol-rich microdomains contain both
bacterial and host proteins involved in microtubule-dependent
trafficking of the inclusion. Second, the cholesterol-binding
protein caveolin may facilitate interactions between the
inclusion and nutrient-rich endosomes and vesicles. In order
to increase cholesterol availability, Chlamydia manipulates
host cell cholesterol homeostasis. Both C. trachomatis and
C. pneumoniae induce LD accumulation, which potentially
provides lipids for bacterial growth. LDs appear particularly
important to C. trachomatis, with bacterial proteins possibly
facilitating translocation and breakdown of LDs in the
inclusion lumen. C. pneumoniae reprograms cholesterol
metabolism, increasing cholesterol levels that contribute
to C. pneumoniae-mediated atherosclerosis and foam cell
formation.
While Chlamydia spp. inclusions divert from the endocytic
pathway, the C. burnetii niche is phagolysosome-like and
highly fusogenic with host endosomes and autophagosomes.
C. burnetii requires lipid rafts for entry into non-phagocytic cells,
although the role of lipid rafts in macrophages has not been
determined. Once inside the cell, the cholesterol requirement
of C. burnetii appears complex and time-dependent. Due to
the fusogenicity of the PV, it is likely that multiple sources
of cholesterol traffic to the PV, though it is unknown how
cholesterol trafficking or cholesterol levels change during PV
development and maintenance. The bacteria are most sensitive
to cholesterol during the initial stages of infection, before
the PV is fully established. One possibility is that cholesterol
regulates the C. burnetii T4SS, which secretes bacterial effector
proteins necessary for PV expansion. Cholesterol also clearly
influences PV pH, which is known to play an important role
in C. burnetii metabolism. C. burnetii appears to have multiple
mechanisms to manipulate host cholesterol levels, including
targeting cholesterol efflux and storage. Further, C. burnetii
may enzymatically modify cholesterol, or use membrane contact
sites to transfer cholesterol from the PV to the host ER.
Finally, our current knowledge of C. burnetii manipulation
of host cholesterol is based on experiments with an avirulent
strain, which contains truncated LPS compared to virulent
bacteria. Studies with virulent bacteria will enable us to
link host cholesterol to disease outcome during C. burnetii
infection.
The importance of cholesterol during A. phagocytophilum,
E. chaffeensis, and Rickettsia spp. infection is comparatively
understudied. A. phagocytophilum and E. chaffeensis utilize
lipid rafts during host cell entry. While A. phagocytophilum
obtains cholesterol by hijacking the host LDL uptake and
NPC1 trafficking, not much is known about E. chaffeensis
and its effect on host cholesterol metabolism. Unlike the
other discussed pathogens, Rickettsia spp. replicate freely
in the cytoplasm and therefore have different cholesterol
requirements than vacuolar pathogens. R. conorii targets
cholesterol during entry, whereas O. tsutsugamushi requires it
during egress from the host cell. Although O. tsutsugamushi
infection increases LD accumulation, if and how these
Rickettsia spp. target host cholesterol metabolism remains
unknown.
Regardless of different bacterial life cycles and host pathways
targeted, host cholesterol manipulation at varying stages
of these intracellular life cycles seems to be the unifying
theme (Table 1). Pathogen-mediated manipulation of host cell
cholesterol metabolism still remains understudied, with a focus
on gene expression analysis and little functional data. An
additional limitation is a lack of in vivo data, which will be
critical to fully understanding the role of cholesterol during
infection. Finally, several questions still remain unanswered:
(1) Is cholesterol manipulation cell type-dependent? (2) Can
other sterols substitute for cholesterol? (3) What is the
advantage of incorporating host cholesterol in the bacterial
membrane? (4) What are the bacterial proteins responsible
for manipulating host cholesterol? (5) Is disease outcome
influenced by the patient cholesterol levels? Answering these
and other questions will provide significant insight into the
role of cholesterol during pathogenesis of obligate intracellular
bacteria.
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